During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...

During a live event, Marc S. Hoffmann, MD, discussed outcomes from the SEQUOIA and ELEVATE-TN studies in chronic lymphocytic ...

BostonGene, a leader in AI-driven molecular and immune profiling that accelerates drug development and personalizes patient care, today announced that four abstracts have been selected for ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

The in-situ visualization of the evolution of metal ... the current state of knowledge of DNA and RNA oligonucleotide hybridization kinetics, discusses new insights into the dynamics of ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Integrated DNA Technologies' new xGen™ Hybridization and Wash v3 Kit is poised to revolutionize targeted next generation sequencing (NGS) workflows. The user-friendly workflow enables NGS cancer ...

Enhertu (fam-trastuzumab deruxtecan-nxki) is currently indicated as a second-line therapy for HER2-positive metastatic breast cancer.

The tenant-in-situ scheme had seen local authorities authorised to step in and buy a rental property if the landlord was selling up, allowing the tenants to remain in place and continue renting.

The global Proteinase K market is set for significant growth, projected to increase from approximately USD 30.2 million in 2025 to USD 48.2 million by 2035, representing a steady CAGR of 4.8% over the ...

Background Morgellons disease (MD) is a complex skin disorder characterized by ulcerating lesions that have protruding or embedded filaments. Many clinicians refer to this condition as delusional ...